Ziconotide, an intrathecally administered N-type calcium channel antagonist for the treatment of chronic pain.
about
Two new 4-Cys conotoxins (framework 14) of the vermivorous snail Conus austini from the Gulf of Mexico with activity in the central nervous system of mice.A Novel Lid-Covering Peptide Inhibitor of Nicotinic Acetylcholine Receptors Derived from αD-Conotoxin GeXXA.Identification of a Novel O-Conotoxin Reveals an Unusual and Potent Inhibitor of the Human α9α10 Nicotinic Acetylcholine ReceptorOptimized deep-targeted proteotranscriptomic profiling reveals unexplored Conus toxin diversity and novel cysteine frameworks.Conorfamide-Sr2, a gamma-carboxyglutamate-containing FMRFamide-related peptide from the venom of Conus spurius with activity in mice and mollusksVenom peptides as a rich source of cav2.2 channel blockers.Peptide pal9a from the venom of the turrid snail Polystira albida from the Gulf of Mexico: purification, characterization, and comparison with P-conotoxin-like (framework IX) conoidean peptidesNovel ω-conotoxins from C. catus reverse signs of mouse inflammatory pain after systemic administration.The Role of Individual Disulfide Bonds of μ-Conotoxin GIIIA in the Inhibition of NaV1.4.Targeting voltage-gated calcium channels for neuropathic pain management.Recent advances in the pharmaceutical management of pain.P/Q-type calcium channel modulators.Therapeutic potential of conopeptides.Omega-conotoxins as experimental tools and therapeutics in pain management.Ziconotide: a clinical update and pharmacologic review.Update on neuropathic pain treatment: ion channel blockers and gabapentinoids.Safety and efficacy of intrathecal drug delivery for pain.Synthetic strategies for polypeptides and proteins by chemical ligation.The Pharmacology of Spinal Opioids and Ziconotide for the Treatment of Non-Cancer Pain.The Proteomics of Intrathecal Analgesic agents for Chronic Pain.Clinical Uses of Intrathecal Therapy and Its Placement in the Pain Care Algorithm.Ziconotide infusion for severe chronic pain: case series of patients with neuropathic pain.Targeting human Mas-related G protein-coupled receptor X1 to inhibit persistent pain.The use of combined spinal-epidural technique to compare intrathecal ziconotide and epidural opioids for trialing intrathecal drug delivery.ω-Conotoxins GVIA, MVIIA and CVID: SAR and Clinical Potential.Omega-conotoxin CVIB differentially inhibits native and recombinant N- and P/Q-type calcium channels.Drugging the undruggable: gabapentin, pregabalin and the calcium channel α2δ subunit.
P2860
Q33315496-43A29F0B-0A8E-4E93-A6DC-CF9FD3B80D4FQ33833362-05C5DA10-B47F-4505-97BD-1C4CA36FAC14Q33833386-A47557BE-049C-47F9-B6CC-B6F0BC7D58BBQ35684927-6677E8F5-2BC0-4C62-9020-4D34DF563056Q36534656-B7B032C8-9A8C-4D20-B400-AE75F3919CCFQ36807192-A54631E8-8CBE-4371-A436-B1B0E444496EQ37310495-2E4B8181-0B05-4A50-9463-48599C9D3201Q37369881-876D233B-030A-45AF-B99B-3A0CD8CB3904Q37453655-FB53C7D6-8131-40AB-A2F3-D99AD86BA2C2Q37605352-2297C11E-A906-4AC6-978A-3A17450FED0CQ37960192-39981EAB-1C7E-4DA3-8E9B-ED848CAA83F4Q38016449-5527B7ED-0352-46A0-BB9E-453CEC64E4CFQ38026605-9C6913C8-6013-42FF-9A46-AA5687DC341CQ38087443-4A10BDD6-1E69-4374-9D13-E63AEAC33B56Q38093859-B74CC575-074A-4B93-B6F4-E675AC534342Q38124283-781F35B2-CBB1-4309-B3D5-4CDA949D705AQ38198087-C2C39D7C-C199-42DF-AAFF-8067A39CDC16Q38430880-3210D9E1-056E-4B71-AB53-6AF8AC71C803Q38727834-AC639E3E-104E-452B-9E2D-688A4ED04388Q38747147-389486FC-856F-43C2-AB0B-400AEF9DD54BQ38749938-FB84541D-6EBC-4BCF-B1C2-65A44D276DB6Q39354418-A6D21171-8580-4487-B2BB-B75AD9E96FE5Q42174123-36BFF852-3BE6-41EE-90BD-DB376BB23D70Q44767792-DA3D63F2-90B6-4DE3-AC2C-3D371B0A77B3Q45805613-551A8422-2FB0-4681-A759-037D5B6E4DA9Q48802729-5E998D8B-B0C1-49F3-A200-46BBA97B4E9EQ53712744-13241BA5-34BC-4A84-AC52-5E16A8D0F793
P2860
Ziconotide, an intrathecally administered N-type calcium channel antagonist for the treatment of chronic pain.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Ziconotide, an intrathecally a ...... the treatment of chronic pain.
@ast
Ziconotide, an intrathecally a ...... the treatment of chronic pain.
@en
type
label
Ziconotide, an intrathecally a ...... the treatment of chronic pain.
@ast
Ziconotide, an intrathecally a ...... the treatment of chronic pain.
@en
prefLabel
Ziconotide, an intrathecally a ...... the treatment of chronic pain.
@ast
Ziconotide, an intrathecally a ...... the treatment of chronic pain.
@en
P2860
P1433
P1476
Ziconotide, an intrathecally a ...... the treatment of chronic pain.
@en
P2093
Daniel P Wermeling
P2860
P304
P356
10.1592/PHCO.2005.25.8.1084
P407
P577
2005-08-01T00:00:00Z